Funds and ETFs Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
38.95 CNY +0.33% Intraday chart for Tuoxin Pharmaceutical Group Co.,Ltd. -8.80% -27.88%

ETFs positioned on Tuoxin Pharmaceutical Group Co.,Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +4.28% -
Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd, is a Chinese company mainly engaged in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates. The Company's main products include pyrimidine series, purine series, nucleotide series, nucleoside series and other series of nucleoside (acid) products, including citicoline sodium, ribavirin, inosine, acyclovir, azvudine, cytosine, 5-fluorocytosine, cytidine, uridine and other raw materials and pharmaceutical intermediates. Its products are mainly used in the fields of virus, anti-tumor and nervous system drugs. The Company mainly distributes its products in domestic market and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 301089 Stock
  4. Funds and ETFs Tuoxin Pharmaceutical Group Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW